Loading clinical trials...
Loading clinical trials...
In this study, we aim to investigate the expression of CKLF like MARVEL transmembrane domain containing 6 (CMTM6) in leukemia cells of patients with acute myeloid leukemia (AML). We will use peripheral blood samples and assess CMTM6 expression by flow cytometry and Western Blot.
Age
18 - 99 years
Sex
ALL
Healthy Volunteers
No
Medical Center- University of Freiburg
Freiburg im Breisgau, CA, Germany
Start Date
May 1, 2020
Primary Completion Date
May 1, 2024
Completion Date
May 1, 2024
Last Updated
May 8, 2024
150
ACTUAL participants
Lead Sponsor
University of Freiburg
NCT06199557
NCT04050280
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions